Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the residue's hydrophobicity. They are the most common impurity in solid-phase synthesis.
Endotoxin and why it is a separate question from purity — what changed since
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species appear. Reducing conditions (like DTT) convert them back.
Worth separating two things that post #66 runs together.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
Picking up post #69: that is the part I would want checked first.
Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural isomer with the same mass but a different sequence. No chromatographic purity method detects this without a reference standard.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the monomer on HPLC depending on the method.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Read the full topic (92 posts)
This topic was referenced in
- Attributing a new peak: degradation product or excipient?Analytics › Impurities & related substances · 2 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Particulates in a reconstituted solution: identifying the likely source
Posting this under the heading it deserves: Particulates in a reconstituted solution: identifying the likely source Everything below is what sits behind that. Posting the method first, because I know what the…
|
+15 | 19 | 13k | 9mo |
|
Racemisation and why it is invisible to a mass measurement — what changed since
Racemisation and why it is invisible to a mass measurement — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I…
|
+11 | 15 | 42k | 16d |
|
Where impurities in solid-phase peptide synthesis come from
Where impurities in solid-phase peptide synthesis come from Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a…
|
+54 | 59 | 14k | 3mo |
|
Residual solvents and scavengers: what is looked for
On the subject in the title: Residual solvents and scavengers: what is looked for Working notes rather than a conclusion. Posting the method first, because I know what the first three replies will otherwise…
|
+19 | 23 | 39k | 14mo |
|
Revisiting: Aggregates and why a purity assay may miss them entirely
Posting this under the heading it deserves: Revisiting: Aggregates and why a purity assay may miss them entirely Everything below is what sits behind that. I would like to understand what this number means…
|
+48 | 53 | 918 | 8mo |
Related topics — sharing the tags HPLC, endotoxin testing, data table
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Why the cheapest option is often not the cheapest
Why the cheapest option is often not the cheapest I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in this…
|
+19 | 23 | 1.2k | 12h |
|
Follow-up: Attributing a new peak: degradation product or excipient?
Attributing a new peak: degradation product or excipient? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
|
+15 | 19 | 671 | 17mo |
|
Comparing prices across jurisdictions without misleading yourself
Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
|
+78 | 83 | 33k | 1mo |
|
A 40-week log with the measurement method stated
On the subject in the title: A 40-week log with the measurement method stated Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a…
|
+87 | 97 | 18k | 9mo |
|
Trifluoroacetate content and its consequences
Trifluoroacetate content and its consequences — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in front of me…
|
+123 | 134 | 31k | 5mo |